Evidence map›Paper›PMID 37250687›Full record

ArticleLancet regional health. Americas2023

Accelerating towards

Narimane Nekkab, Thomas Obadia, Wuelton M Monteiro, Marcus V G Lacerda, Michael White, Ivo Mueller

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Integrating parallelCommunications health · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Narimane NekkabInstitut Pasteur, Université Paris Cité, G5 Épidémiologie et Analyse des Maladies Infectieuses, Paris, France.
Thomas ObadiaInstitut Pasteur, Université Paris Cité, G5 Épidémiologie et Analyse des Maladies Infectieuses, Paris, France.
Wuelton M MonteiroEscola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Brazil.
Marcus V G LacerdaDiretoria de Ensino e Pesquisa, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Michael WhiteInstitut Pasteur, Université Paris Cité, G5 Épidémiologie et Analyse des Maladies Infectieuses, Paris, France.
Ivo MuellerPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Institut Pasteur · FRFundação de Medicina Tropical · BRThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Using a previously developed mathematical model of Findings: Deploying a single round of Interpretation: Modelling predicts that mass campaigns with Funding: This project was funded in part by the Bill and Melinda Gates Foundation and the National Health and Medical Research Council.

Indexed as

EliminationMalariaMass screeningMathematical modellingPlasmodium vivaxRadical cureSerological diagnosticsTreatment

Identifiers

PMID37250687
PMCPMC10209700
OpenAlexW4377102817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.